MarketInOut Stock Screener Log In | Sign Up
 

ARS Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/08/2026 16:00
ARS Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization426.63 mln
Float65.25 mln
Earnings Date11/17/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-2.98
Likely reliable

1-Year Forecast

22.50
Transformational upside

Relative Strength

95 / 100
Top performer

Debt / Equity

7.73
Extremely leveraged

Pre-Tax Margin

-184%
Severely loss-making

Business Description

ARS Pharmaceuticals is a San Diego-based drug company focused on making emergency allergy treatments more accessible. Its main product, neffy, delivers epinephrine through the nose rather than by injection, offering a needle-free option for people experiencing severe allergic reactions such as anaphylaxis. Founded in 2015, the company sells its products in the United States and abroad.

Key Fundamentals

EPS-2.18
ROE-204
RPS1.18
ROIC-471
ROA-69.45
Interest Cover-43.96
EBITDA, mln-209
EV / EBITDA-1.83
EV / EBIT-1.81
Revenue, mln117
EV / Revenue3.26

Quote Details

Last 4.56
Change 0.2 (4.59%)
Open 4.35
Volume 1,584,824
Turnover 7,226,798
Average Volume 1,557,291

Financial Ratios

Pre-Tax Profit Margin-184
Leverage Ratio19.94
Current Ratio3.48
Price / Book33.23
Debt / Equity7.73
Price / Sales3.65

Financial Strength

Altman Z-Score-2.83
Piotroski F-Score 1 / 9
Beneish M-Score-2.98
1-Year Target Price22.50
Short Ratio14.55
Short % of Float33.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.68% 97 / 100   
1 Month -12.81% 19 / 100   
2 Months -46.73% 8 / 100   
6 Months -44.86% 11 / 100   
1 Year -55.86% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us